BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 19067917)

  • 1. Immunotherapy with autologous dendritic cells and tumor antigens for children with refractory malignant solid tumors.
    Suminoe A; Matsuzaki A; Hattori H; Koga Y; Hara T
    Pediatr Transplant; 2009 Sep; 13(6):746-53. PubMed ID: 19067917
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of CD34+ progenitor-derived dendritic cells pulsed with tumor cell lysate for a vaccination strategy in children with malignant solid tumors and a poor prognosis.
    Ackermann B; Tröger A; Glouchkova L; Körholz D; Göbel U; Dilloo D
    Klin Padiatr; 2004; 216(3):176-82. PubMed ID: 15175963
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immunotherapy using autologous monocyte-derived dendritic cells pulsed with leukemic cell lysates for acute myeloid leukemia relapse after autologous peripheral blood stem cell transplantation.
    Lee JJ; Kook H; Park MS; Nam JH; Choi BH; Song WH; Park KS; Lee IK; Chung IJ; Hwang TJ; Kim HJ
    J Clin Apher; 2004; 19(2):66-70. PubMed ID: 15274198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Induction of cytolytic T lymphocytes against pediatric solid tumors in vitro using autologous dendritic cells pulsed with necrotic primary tumor.
    Shilyansky J; Jacobs P; Doffek K; Sugg SL
    J Pediatr Surg; 2007 Jan; 42(1):54-61; discussion 61. PubMed ID: 17208541
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Vaccination of pediatric solid tumor patients with tumor lysate-pulsed dendritic cells can expand specific T cells and mediate tumor regression.
    Geiger JD; Hutchinson RJ; Hohenkirk LF; McKenna EA; Yanik GA; Levine JE; Chang AE; Braun TM; Mulé JJ
    Cancer Res; 2001 Dec; 61(23):8513-9. PubMed ID: 11731436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Haploidentical stem cell transplantation in patients with pediatric solid tumors: preliminary results of a pilot study and analysis of graft versus tumor effects.
    Lang P; Pfeiffer M; Müller I; Schumm M; Ebinger M; Koscielniak E; Feuchtinger T; Föll J; Martin D; Handgretinger R
    Klin Padiatr; 2006; 218(6):321-6. PubMed ID: 17080334
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo cytokine responses to interleukin-2 immunotherapy after autologous stem cell transplantation in children with solid tumors.
    Bönig H; Laws HJ; Wundes A; Verheyen J; Hannen M; Kim YM; Banning U; Nürnberger W; Körholz D
    Bone Marrow Transplant; 2000 Jul; 26(1):91-6. PubMed ID: 10918410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Allogeneic GM-CSF-secreting tumor cell immunotherapies generate potent anti-tumor responses comparable to autologous tumor cell immunotherapies.
    Li B; Simmons A; Du T; Lin C; Moskalenko M; Gonzalez-Edick M; VanRoey M; Jooss K
    Clin Immunol; 2009 Nov; 133(2):184-97. PubMed ID: 19664962
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High-dose iodine-131-metaiodobenzylguanidine with haploidentical stem cell transplantation and posttransplant immunotherapy in children with relapsed/refractory neuroblastoma.
    Toporski J; Garkavij M; Tennvall J; Ora I; Gleisner KS; Dykes JH; Lenhoff S; Juliusson G; Scheding S; Turkiewicz D; Békássy AN
    Biol Blood Marrow Transplant; 2009 Sep; 15(9):1077-85. PubMed ID: 19660720
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nonviral transfection of human umbilical cord blood dendritic cells is feasible, but the yield of dendritic cells with transgene expression limits the application of this method in cancer immunotherapy.
    Markowicz S; Niedzielska J; Kruszewski M; Ołdak T; Gajkowska A; Machaj EK; Skurzak H; Pojda Z
    Acta Biochim Pol; 2006; 53(1):203-12. PubMed ID: 16404477
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Results of a Phase I study utilizing monocyte-derived dendritic cells pulsed with tumor RNA in children with Stage 4 neuroblastoma.
    Caruso DA; Orme LM; Amor GM; Neale AM; Radcliff FJ; Downie P; Tang ML; Ashley DM
    Cancer; 2005 Mar; 103(6):1280-91. PubMed ID: 15693021
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GMP production of anti-tumor cytotoxic T-cell lines for adoptive T-cell therapy in patients with solid neoplasia.
    Turin I; Pedrazzoli P; Tullio C; Montini E; La Grotteria MC; Schiavo R; Perotti C; Locatelli F; Carretto E; Maccario R; Siena S; Montagna D
    Cytotherapy; 2007; 9(5):499-507. PubMed ID: 17786611
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Infiltration of activated dendritic cells and T cells in renal cell carcinoma following combined cytokine immunotherapy.
    Verra N; de Jong D; Bex A; Batchelor D; Dellemijn T; Sein J; Nooijen W; Meinhardt W; Horenblas S; de Gast G; Vyth-Dreese F
    Eur Urol; 2005 Sep; 48(3):527-33. PubMed ID: 16115526
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent advances of dendritic cells (DCs)-based immunotherapy for malignant gliomas.
    Cho DY; Lin SZ; Yang WK; Hsu DM; Lee HC; Lee WY; Liu SP
    Cell Transplant; 2009; 18(9):977-83. PubMed ID: 19523342
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phase 1/2 study of immunotherapy with dendritic cells pulsed with autologous tumor lysate in patients with refractory bone and soft tissue sarcoma.
    Miwa S; Nishida H; Tanzawa Y; Takeuchi A; Hayashi K; Yamamoto N; Mizukoshi E; Nakamoto Y; Kaneko S; Tsuchiya H
    Cancer; 2017 May; 123(9):1576-1584. PubMed ID: 28241093
    [TBL] [Abstract][Full Text] [Related]  

  • 16. KIR-HLA receptor-ligand mismatch associated with a graft-versus-tumor effect in haploidentical stem cell transplantation for pediatric metastatic solid tumors.
    Pérez-Martínez A; Leung W; Muñoz E; Iyengar R; Ramírez M; Vicario JL; Lassaletta A; Sevilla J; González-Vicent M; Madero L; Díaz-Pérez MA
    Pediatr Blood Cancer; 2009 Jul; 53(1):120-4. PubMed ID: 19215002
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dendritic cell activation by combined exposure to anti-CD40 plus interleukin (IL)-12 and IL-18 efficiently stimulates anti-tumor immunity.
    Balkow S; Loser K; Krummen M; Higuchi T; Rothoeft T; Apelt J; Tuettenberg A; Weishaupt C; Beissert S; Grabbe S
    Exp Dermatol; 2009 Jan; 18(1):78-87. PubMed ID: 19054060
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Surgical excision combined with autologous whole tumor cell vaccination is an effective therapy for murine neuroblastoma.
    Ohashi K; Kobayashi G; Fang S; Zhu X; Antonia SJ; Krieg AM; Sandler AD
    J Pediatr Surg; 2006 Aug; 41(8):1361-8. PubMed ID: 16863838
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunotherapy against metastatic renal cell carcinoma with mature dendritic cells.
    Matsumoto A; Haraguchi K; Takahashi T; Azuma T; Kanda Y; Tomita K; Kurokawa M; Ogawa S; Takahashi K; Chiba S; Kitamura T
    Int J Urol; 2007 Apr; 14(4):277-83. PubMed ID: 17470153
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Administration of dendritic cells in cancer nodules in hepatocellular carcinoma.
    Kumagi T; Akbar SM; Horiike N; Kurose K; Hirooka M; Hiraoka A; Hiasa Y; Michitaka K; Onji M
    Oncol Rep; 2005 Oct; 14(4):969-73. PubMed ID: 16142359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.